MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASE
- 31 March 1981
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 317 (8225), 858-860
- https://doi.org/10.1016/s0140-6736(81)92138-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A case-control study of menopausal estrogen therapy and breast cancerJAMA, 1980
- ESTIMATION OF MULTIPLE RELATIVE RISK FUNCTIONS IN MATCHED CASE-CONTROL STUDIESAmerican Journal of Epidemiology, 1978
- Menopause and Coronary Heart DiseaseAnnals of Internal Medicine, 1978
- CORONARY RISK AND ESTROGEN USE IN POSTMENOPAUSAL WOMEN1American Journal of Epidemiology, 1978
- ESTROGENS AND ATHEROSCLEROSISClinical Obstetrics and Gynecology, 1976
- EVIDENCE FOR HYPERŒSTROGENÆMIA AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MENThe Lancet, 1976
- Estrogens and Endometrial Cancer in a Retirement CommunityNew England Journal of Medicine, 1976
- Myocardial Infarction and Estrogen Therapy in Post-Menopausal WomenNew England Journal of Medicine, 1976
- The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research GroupPublished by American Medical Association (AMA) ,1973
- Increased Incidence of Coronary Heart Disease in Women Castrated Prior to the MenopauseArchives of Internal Medicine, 1959